Shana Thomas

973 total citations
9 papers, 259 citations indexed

About

Shana Thomas is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Shana Thomas has authored 9 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Shana Thomas's work include Advanced Breast Cancer Therapies (7 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer-related Molecular Pathways (3 papers). Shana Thomas is often cited by papers focused on Advanced Breast Cancer Therapies (7 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer-related Molecular Pathways (3 papers). Shana Thomas collaborates with scholars based in United States. Shana Thomas's co-authors include X. Cynthia, Jingqin Luo, Jing Xi, Foluso O. Ademuyiwa, Rama Suresh, Bilal Hassan, Jian Campian, Zhanfang Guo, Matthew J. Ellis and Jeremy Hoog and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Cancer Letters.

In The Last Decade

Shana Thomas

9 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shana Thomas United States 5 181 165 72 70 65 9 259
Farida Souami United States 6 178 1.0× 163 1.0× 35 0.5× 70 1.0× 35 0.5× 7 264
IA Mayer United States 9 236 1.3× 170 1.0× 50 0.7× 66 0.9× 88 1.4× 25 297
Jon S. Dubois United States 3 209 1.2× 212 1.3× 61 0.8× 91 1.3× 65 1.0× 4 285
T. Valdez United States 6 274 1.5× 153 0.9× 27 0.4× 66 0.9× 40 0.6× 17 326
Elisa Minenza Italy 9 182 1.0× 117 0.7× 17 0.2× 31 0.4× 59 0.9× 12 245
G. Lieberman United States 5 148 0.8× 85 0.5× 22 0.3× 40 0.6× 99 1.5× 9 231
Danai Fimereli Belgium 7 211 1.2× 67 0.4× 15 0.2× 140 2.0× 63 1.0× 10 294
Peter Schmid United States 5 227 1.3× 113 0.7× 20 0.3× 48 0.7× 27 0.4× 11 268
Chelsea Andrews United States 8 289 1.6× 120 0.7× 25 0.3× 60 0.9× 31 0.5× 17 320
Christianne Hoey Canada 9 134 0.7× 180 1.1× 38 0.5× 218 3.1× 230 3.5× 10 413

Countries citing papers authored by Shana Thomas

Since Specialization
Citations

This map shows the geographic impact of Shana Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shana Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shana Thomas more than expected).

Fields of papers citing papers by Shana Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shana Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shana Thomas. The network helps show where Shana Thomas may publish in the future.

Co-authorship network of co-authors of Shana Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Shana Thomas. A scholar is included among the top collaborators of Shana Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shana Thomas. Shana Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Clifton, Katherine, X. Cynthia, Jingqin Luo, et al.. (2024). Abstract PO5-05-05: Clinical outcomes of CDK4/6 inhibitors in patients with bone only metastatic breast cancer. Cancer Research. 84(9_Supplement). PO5–5. 1 indexed citations
2.
Thomas, Shana, et al.. (2023). Abstract P2-23-10: Gene expression and mutation profiles in HER2-mutated metastatic breast cancer. Cancer Research. 83(5_Supplement). P2–23. 1 indexed citations
3.
Krishnamurthy, Jairam, Jingqin Luo, Rama Suresh, et al.. (2022). A phase II trial of an alternative schedule of palbociclib and embedded serum TK1 analysis. npj Breast Cancer. 8(1). 35–35. 5 indexed citations
4.
5.
Xi, Jing, Amit M. Oza, Shana Thomas, et al.. (2019). Retrospective Analysis of Treatment Patterns and Effectiveness of Palbociclib and Subsequent Regimens in Metastatic Breast Cancer. Journal of the National Comprehensive Cancer Network. 17(2). 141–147. 61 indexed citations
6.
Xi, Jing, Jingqin Luo, Bilal Hassan, et al.. (2019). Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer. Breast Cancer Research and Treatment. 174(2). 443–452. 54 indexed citations
7.
Bagegni, Nusayba A., Shana Thomas, Ning Liu, et al.. (2017). Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib. Breast Cancer Research. 19(1). 123–123. 53 indexed citations
8.
Cynthia, X., Jingqin Luo, Michael Naughton, et al.. (2015). A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor–Positive Metastatic Breast Cancer. Clinical Cancer Research. 22(7). 1583–1591. 77 indexed citations
9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Farida Souami Breakdown of academic impact, for papers by IA Mayer Breakdown of academic impact, for papers by Jon S. Dubois Breakdown of academic impact, for papers by T. Valdez Breakdown of academic impact, for papers by Elisa Minenza Breakdown of academic impact, for papers by G. Lieberman Breakdown of academic impact, for papers by Danai Fimereli Breakdown of academic impact, for papers by Peter Schmid Breakdown of academic impact, for papers by Chelsea Andrews Breakdown of academic impact, for papers by Christianne Hoey
Rankless by CCL
2026